Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?
Authors
Keywords
Radiation therapy, Cancer treatment, Metastasis, Prostate cancer, Prostate gland, Toxicity, Cancer detection and diagnosis, Oncology
Journal
PLoS One
Volume 11, Issue 1, Pages e0147191
Publisher
Public Library of Science (PLoS)
Online
2016-01-26
DOI
10.1371/journal.pone.0147191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
- (2017) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
- (2015) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Castration-resistant prostate cancer: latest evidence and therapeutic implications
- (2014) Daniel L. Suzman et al. Therapeutic Advances in Medical Oncology
- Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial
- (2013) Christopher C. Parker et al. BJU INTERNATIONAL
- Limited M1 Disease: A Significant Prognostic Factor for Stage IV Breast Cancer
- (2012) David H. A. Nguyen et al. ANNALS OF SURGICAL ONCOLOGY
- Can Locoregional Treatment of the Primary Tumor Improve Outcomes for Women With Stage IV Breast Cancer at Diagnosis?
- (2012) David H.A. Nguyen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local treatment of metastatic cancer—killing the seed or disturbing the soil?
- (2011) Scott C. Morgan et al. Nature Reviews Clinical Oncology
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer
- (2010) Jutta Engel et al. EUROPEAN UROLOGY
- Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)
- (2010) Mette Nørgaard et al. JOURNAL OF UROLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis
- (2010) Michael D. Staehler et al. WORLD JOURNAL OF UROLOGY
- PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation
- (2009) Samuel D. McGrath et al. Brachytherapy
- Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
- (2009) Dorothea Weckermann et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer
- (2008) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions
- (2008) Ik Jae Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started